(Reuters) – Canada on Tuesday updated its guideline to recommend use of AstraZeneca’s COVID-19 vaccine in people aged 65 years and older.
The National Advisory Committee on Immunization said it had considered recent real-world effectiveness studies to inform this change in recommendation. (https://bit.ly/3thLc1Q)
(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
